The Elegant Bioweapon - Research

Read - Debate - Retort

Please find pertinent research links below that were utilized. Totally realize no one will read any of the attached but at least it is there for the record. As it was put to me: “posting lists of scientific documents is futile” (tend to agree - sorry for the boring post).

The Elegant Bioweapon - A Love Story

Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2

SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration

Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer’s disease individuals

Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID

5G + Aluminum - Aluminum modulates brain amyloidosis through oxidative stress

SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome

Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues

Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression

Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2

A glycan gate controls opening of the SARS-CoV-2 spike protein

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase activity in Platelets Controls Translational Events Through RNA–DNA Hybrids

Be aware of SARS-CoV-2 spike protein: There is more than meets the eye

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

Amyloidogenesis of SARS-CoV-2 Spike Protein

The effect of SARS-COV-2 Infections on Amyloid Formation of Serum Amyloid A

Amyloidosis and COVID‑19: experience from an amyloid program in Canada

Amyloid processing in COVID-19-associated neurological syndromes

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1

Lysosomotropic Agents and Cysteine Protease Inhibitors Inhibit Scrapie-Associated Prion Protein Accumulation

Expert statement regarding the use of Moderna COVID-19-mRNA-Vaccine in children

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

THE NOVEL CORONAVIRUS’ SPIKE PROTEIN PLAYS ADDITIONAL KEY ROLE IN ILLNESS

SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2

SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro

An insight into neurotoxic and toxicity of spike fragments SARS-CoV-2 by exposure environment

Review of COVID-19 Vaccines and the Risk of Chronic Adverse Events Including Neurological Degeneration

SARS-CoV-2 prion-like domains in spike proteins enable higher affinity to ACE2

Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Twenty six cases of CJD declared a few days after a COVID-19 “vaccine” Jab

Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation

The pathophysiology of ‘happy’ hypoxemia in COVID-19

Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron

Amyloidoses and Prion Diseases

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus

Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome Sequencing

Risk factor for developing Alzheimer's disease increases by 50-80% in older adults who caught COVID-19

Therapeutic Approaches to the Neurologic Manifestations of COVID‑19

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

Transposons - The Landscape of L1 Retrotransposons in the Human Genome Is Shaped by Pre-insertion Sequence Biases and Post-insertion Selection

CRISPR - CRISPRing or RISKing? Dangers Arising from Gene Editing with CRISPR-Cas9

Somatic APP gene recombination and mutations occur mosaically in normal and Alzheimer’s disease neurons

RNAs That Behave Like Prions

Human Immunodeficiency Virus Type 1 Alters BrainDerived Neurotrophic Factor Processing in Neurons

Up-regulated microRNA-132 reduces the cognition-damaging effect of sevoflurane on Alzheimer's disease rats by inhibiting FOXA1

Enhanced activity of Alzheimer disease associated variant of protein kinase Cα drives cognitive decline in a mouse model

The neurovascular unit, matrix proteases, and innate inflammation

Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation

Apparently this does not exist (haha Word Herder) - Severe acute respiratory syndrome coronavirus 2 isolate SARS-CoV-2/human/2020, complete genome sequence

Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing

Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2

Endonuclease fingerprint indicates a synthetic origin of SARS-CoV-2

SARS-COV2 VARIANTS AND VACCINES MRNA SPIKES FIBONACCI NUMERICAL UA/CG METASTRUCTURES

Gain-of-Function’ Hall of Shame

Gain of function - The Evidence which Suggests that This Is No Naturally Evolved Virus

Gain of function - Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response

Gain of function - COVID-19, SARS and Bats Coronaviruses Genomes Unexpected Exogeneous RNA Sequences

Gain of function - An open debate on SARS-CoV-2’s proximal origin is long overdue

Gain of function - The genetic structure of SARS-CoV-2 does not rule out a laboratory origin SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation

Gain of function - Outlines of a probabilistic evaluation of possible SARS-CoV-2 origins

Gain of function - Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin

Gain of function - Superantigenic character of an insert unique to SARS-CoV-2 spike

Gain of function - Endonuclease fingerprint indicates a synthetic origin of SARS-CoV-2

Gain of function - Engineered bat virus stirs debate over risky research - Lab-made coronavirus related to SARS can infect human cells.

Gain of function - Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function

Gain of function - Derivation of a novel SARS–coronavirus replicon cell line and its application for anti-SARS drug screening

Gain of function - Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation

Bioweapon

Unusual Features of the SARS-CoV-2 Genome Suggesting Sophisticated Laboratory Modification Rather Than Natural Evolution and Delineation of Its Probable Synthetic Route

Evidence SARS-CoV-2 Emerged From a Biological Laboratory in Wuhan, China

Dr. David E. Martin - The Fauci/Covid-19 Dossier

SARS-CoV-2 Is an Unrestricted Bioweapon: A Truth Revealed through Uncovering a Large-Scale, Organized Scientific Fraud

Should we discount the laboratory origin of COVID‑19?

The Origins of Covid-19 - An Investigation of the Wuhan Institute of Virology

COVID-19 and Illegal US Bioweapons Activity, an Insider's Revelations

Patents

Methods and compositions for chimeric coronavirus spike proteins

INSERTON OF FURIN PROTEASE CLEAVAGE SITES IN MEMBRANE PROTEINS AND USES THEREOF

PROCESS FOR AMPLIFYING, DETECTING, AND/OR-CLONING NUCLEIC ACID SEQUENCES

Methods for producing recombinant coronavirus